LATEST ALERTS
Regulatory report: Slovenia, December 2021
2nd December 2021 - Regulatory reports |
Slovenia’s stance on CBD in the light of the Kanavape case isn’t clear; recreational cannabis rules not likely change; medicinal cannabis rules might change
Regulation and legislation
Little stands in the way of Germany legalising recreational cannabis by 2024
30th November 2021 - News analysis |
The incoming German ‘traffic light’ coalition government’s promise to legalise recreational cannabis for adults puts it on track to be the first major European nation to take such action
CBD-Intel regulatory news in brief, 20th-26th November
26th November 2021 - Alerts , Regulatory alerts roundup |
This week’s regulatory news in brief includes updates from Austria, Belgium, Germany, Luxembourg, Malta, UK, US, Argentina, Brazil, India, Israel, Panama and Thailand
Republican bill could create ingestible CBD pathway, but passage remains iffy
26th November 2021 - News analysis |
Nancy Mace, a first-term Republican Congresswoman from South Carolina, recently introduced a bill in the House of Representatives that would decriminalise cannabis at the federal level
Top South Dakota court overturns ballot bid to legalise recreational cannabis
25th November 2021 - News analysis |
Legal recreational cannabis in South Dakota will have to wait following the state Supreme Court’s controversial decision to invalidate Amendment A, a ballot initiative passed by voters a year ago
Malawi asks former world boxing champ Tyson to be cannabinoids ambassador
25th November 2021 - News analysis |
Malawi has asked former world heavyweight boxing chamption Mike Tyson to be ambassador for its cannabinoid industry, where new legislation is coming in. A civil rights group opposes this
Podcast: A UK doctor’s take on CBD
25th November 2021 - Podcasts |
CBD-Intel podcast editor Jon Bruford meets Dr K CBD’s Dr Ruchira Karunadasa who explains why he believes the company has an important role to play in helping the industry towards mature dialogue, and the impact that
New German coalition plans to legalise cannabis – but when will sales begin?
25th November 2021 - Blogs , News analysis |
The newly elected German governing coalition has followed through on pre-election promises and included a plan for cannabis legalisation in its coalition agreement – but many questions remain to be answered
Hempro returns to German courts in bid to overturn rejection of hemp imports
24th November 2021 - News analysis |
A German hemp producer and retailer is going to court hoping to overturn a rejection of its application to import hemp products from Austria. The new German government may pre-empt matters if it makes cannabis sales legal
CBD-Intel regulatory news in brief, 13th-19th November
19th November 2021 - Alerts , Regulatory alerts roundup |
This week’s regulatory news in brief includes updates from France, Germany, Malta, Slovenia, Ukraine, the US, Argentina, Brazil, Colombia, Israel, Malaysia, Sri Lanka and Uruguay
Switzerland heads towards cannabis legalisation, but some hurdles remain
19th November 2021 - News analysis |
Switzerland inched closer towards legalising recreational and medical cannabis as a committee of the upper parliamentary chamber backed a proposal to regulate the market
Russia plans to bring light to the grey area of industrial hemp definitions
18th November 2021 - News analysis |
The Russian Ministry of Industry and Trade is planning to clarify the definitions of definition of industrial hemp and the varieties that can be cultivated for industrial purposes by March/April 2022
CBD-Intel regulatory news in brief, 6th-12th November
12th November 2021 - Alerts , Regulatory alerts roundup |
This week’s regulatory news in brief includes updates from Georgia, Canada, Mexico, the US, Chile, Colombia, India, Japan, Malaysia, Russia and Thailand
CBD-Intel regulatory news in brief, 30th October-5th November
5th November 2021 - Alerts , Regulatory alerts roundup |
This week’s regulatory news in brief includes updates from Portugal, the UK, US, Brazil and Chile
CBD-Intel regulatory news in brief, 23rd-29th October
29th October 2021 - Alerts , Regulatory alerts roundup |
This week’s regulatory news in brief includes updates from France, Finland, Germany, Italy, Lithuania, Switzerland, Ukraine, Canada, the US, Argentina, Brazil, Chile, China, Costa Rica, India New Zealand, Peru and Thailand
Italian cannabis referendum looks likely to go ahead despite teething troubles
27th October 2021 - News analysis |
Italian campaigners believe they have done enough to secure a referendum on the legalisation of cannabis cultivation for personal use and the decriminalisation of possession
CBD-Intel regulatory news in brief, 16th-22nd October
22nd October 2021 - Alerts , Regulatory alerts roundup |
This week’s regulatory news in brief includes updates from the EU, Luxembourg, Portugal, Spain, Switzerland, UK, Canada, Mexico, US, Brazil, Costa Rica, Moldova, Russia
France facing legal battle over coming decree to ban the sale of CBD flowers
19th October 2021 - News analysis |
The French ban on CBD flowers looks set to go ahead, with a decree expected to be officially published at the start of November – and an immediate legal appeal against it likely
CBD-Intel regulatory news in brief, 9th-15th October
15th October 2021 - Alerts , Regulatory alerts roundup |
This week’s regulatory news in brief includes updates from Germany, Ireland, the US, Chile, Malaysia, Nepal, New Zealand, Panama and Pakistan
CBD-Intel regulatory news in brief, 2nd-8th October
8th October 2021 - Alerts , Regulatory alerts roundup |
This week’s regulatory news in brief includes updates from Spain, US, Mexico, Argentina, Chile, Malaysia and New Zealand
Panama leads the way with Central America’s first legal medical cannabis
5th October 2021 - News analysis |
Panama is set to become the first country in Central America to legalise and regulate medicinal cannabis after the 44-member National Assembly voted unanimously in favour of doing so
Regulatory report: Chile, October 2021
5th October 2021 - Regulatory reports |
Chile has maintained a rather restrictive approach towards hemp and CBD. It has only recently allowed medicinal use of cannabis-based products, but there are still many legal grey areas as a consequence of the lack of regulation
CBD-Intel regulatory news in brief, 25th September-1st October
1st October 2021 - Alerts , Regulatory alerts roundup |
This week’s regulatory news in brief includes updates from Czech Republic, Germany, Ireland, Spain, Portugal, the US, Ecuador, Malaysia and Thailand
Regulatory report: cannabis delivery in the US
29th September 2021 - Regulatory reports |
This regulatory report examines which of the 36 US states that have legalised medical and/or recreational cannabis sales allow for home deliveries of cannabis products
CBD-Intel regulatory news in brief, 18th-24th September
24th September 2021 - Alerts , Regulatory alerts roundup |
This week’s regulatory news in brief includes updates from Germany, Hungary, Italy, Lithuania, Spain, the US, Colombia and Uruguay
What does the recent USPTO trademark decision mean for the industry?
22nd September 2021 - Blogs , News analysis |
The USPTO Appeals Board verdict upholding the USPTO’s decision to not grant Joy Tea a trademark covering CBD beverages should come as no surprise
Resistant legislators deny Kentucky and Tennessee access to medical cannabis
21st September 2021 - News analysis |
Kentucky and Tennessee are among a large number of Southeastern US states that have not yet passed legislation for medical cannabis programs. Here, CBD-Intel examines the issues behind the official reluctance
CBD-Intel regulatory news in brief, 11th-17th September
17th September 2021 - Alerts , Regulatory alerts roundup |
This week’s regulatory news in brief includes updates from Czech Republic, EU, Finland, Ireland, Italy, Portugal, Spain, UK, US and Costa Rica
Delta-8 THC regulation in the US
13th September 2021 - Presentations , Resources |
What is delta-8 THC and how does US law deal with it, at both federal and state level? In this presentation, CBD-Intel legal analyst Anthony Traurig shares his insights
CBD-Intel regulatory news in brief, 4th-10th September
10th September 2021 - Alerts , Regulatory alerts roundup |
This week’s regulatory news in brief includes updates from Belgium, Ireland, Italy, UK, US, China, Namibia, Nigeria and Zimbabwe
CBD-Intel regulatory news in brief, 28th August-3rd September
3rd September 2021 - Alerts , Regulatory alerts roundup |
This week’s regulatory news in brief includes updates from Italy, Germany, Portugal, Spain, Mexico, the US, Belize, China, Colombia, Japan, Malaysia, Panama, South Africa, Thailand and Uruguay
Lagging behind: why Wyoming and Idaho are still to legalise medical cannabis
3rd September 2021 - News analysis |
There are now only 14 US states that have yet to implement a medical cannabis programme. Why they are behind the curve on the issue is something of a mystery
Approved by EU – so why was Finola hemp tested and banned in Poland?
2nd September 2021 - News analysis |
Crops of a hemp variety found by Polish authorities to be over the THC limit should never have been tested and regulators are refusing to say why they were, the creator of the variety alleges
Could Colombia’s reversal on allowing medical cannabis flower exports impact the global market?
1st September 2021 - Blogs , News analysis |
There are always people claiming that new changes mean some such country will be “The next big X in cannabis or hemp”. Recent examples include North Macedonia, Thailand, Brazil, Paraguay, Lesotho, Malawi, and of course, Colombia
CBD-Intel regulatory news in brief, 21st-27th August
27th August 2021 - Alerts , Regulatory alerts roundup |
This week’s regulatory news in brief includes updates from Bosnia and Herzegovina, Croatia, Germany, Spain, Switzerland, the US, Costa Rica, Morocco and Panama
‘Transcendental change’ as president opens up Colombia to flower exports
26th August 2021 - News analysis |
“Today, Colombia eliminates the prohibition of dried flower exports,” president Iván Duque said. “This means that Colombia will enter and participate in the international market in a big way.”
Regulatory report: US state-by-state regulation of CBD vaping products
25th August 2021 - Regulatory reports |
This report covers, state by state, the question of whether each US state allows the sale of hemp-derived CBD vaping products and on what legal terms
Brazil’s bill to legalise hemp and medical cannabis runs into a further snag
24th August 2021 - News analysis |
A bill to legalise the cultivation and processing of hemp and medical cannabis in Brazil has been dealt a blow with a call for it to be debated and voted on by the country’s full Chamber of Deputies before it is put to the Senate
Positive regulatory changes for CBD, hemp and cannabis in Uruguay
23rd August 2021 - News analysis |
Uruguay is expected to become one of the first countries to officially legalise the use of CBD in ingestible products
CBD-Intel regulatory news in brief, 14th-20th August
20th August 2021 - Alerts , Regulatory alerts roundup |
This week’s regulatory news in brief includes updates from the EU, Germany, the US, Fiji and Japan
Regulatory report: Portugal, August 2021
17th August 2021 - Regulatory reports |
This report covers the current legal regime for hemp, CBD and cannabis in Portugal
CBD-Intel regulatory news in brief, 7th-13th August
13th August 2021 - Alerts , Regulatory alerts roundup |
This week’s regulatory news in brief includes updates from Netherlands, Spain, Poland, the US and Guyana
Medical use of psilocibyn in Canada could grow, but consumer sale unlikely
13th August 2021 - News analysis |
A court case could force the Canadian government to process requests to use psilocybin for psychotherapeutic treatment more quickly
What lies behind the CBD industry’s continued interest in the field of nicotine replacement?
11th August 2021 - Blogs , News analysis |
A new study has shown some limited effectiveness for the use of CBD in combatting nicotine withdrawal symptoms
Spain’s PSOE has a change of heart over legalising medical cannabis
11th August 2021 - News analysis |
Members of Spain’s ruling party are warming to the idea of legalising medicinal cannabis just months after claiming scientific evidence was insufficient to support such an initiative
New regulations spell positive steps for Thailand’s cannabis and hemp industry
9th August 2021 - News analysis |
A series of changes in Thai law governing both medical cannabis and hemp has made the country one of the most cannabinoid-friendly countries in Asia
CBD-Intel regulatory news in brief, 31st July-6th August
6th August 2021 - Alerts , Regulatory alerts roundup |
This week’s regulatory news in brief includes updates from Spain, the UK, the US, Australia, Colombia, Costa Rica, Ecuador and Israel
Could e-cig ‘shake and vape’ be a model for sales of ingestible CBD products?
5th August 2021 - Blogs , News analysis |
There remains no certainty over the future regulation of ingestible CBD products in many jurisdictions
Three states lay out a possible roadmap for US regulation of delta-8 products
2nd August 2021 - News analysis |
Three US states where recreational cannabis states is legal have now moved to regulate hemp-derived delta-8 THC products by placing them under their state cannabis programmes
CBD-Intel regulatory news in brief, 24th-30th July
30th July 2021 - Alerts , Regulatory alerts roundup |
This week’s regulatory news in brief includes updates from Czech Republic, Germany, Spain, the US and Colombia
